Clinicas MI Doctor is categorized under Primary Care Centers in Bellaire, TX and active since 2010.
Clinicas MI Doctor was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Michelle Vicente, Manager at the company’s single location by writing to 5835 Bissonnet St, Bellaire, Texas TX 77401 or by phoning (713) 715-4440. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinicas MI Doctor |
| Contact Person: | Michelle Vicente, Manager |
| Address: | 5835 Bissonnet St, Bellaire, Texas 77401 |
| Phone Number: | (713) 715-4440 |
| Website Address: | clinicasmidoctor.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Clinicas MI Doctor was started in 2010 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michelle Vicente, Manager for inquiries that concern Clinicas MI Doctor by calling the company number (713) 715-4440, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinicas MI Doctor can be found at the coordinates 29.69928,-95.48411 as well as the street address 5835 Bissonnet St in Bellaire, Texas 77401.
For its online presence, you may visit Clinicas MI Doctor’s website at clinicasmidoctor.com and engage with its social media outlets through on Twitter and on Facebook.